Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint

Core Insights - Delcath Systems, Inc. announced the results of the CHOPIN randomized Phase 2 clinical trial focused on treating primary and metastatic liver cancers [1] Company Summary - Delcath Systems, Inc. is an interventional oncology company [1] - The CHOPIN Trial was presented by Professor Ellen Kapiteijn from Leiden University Medical Center at the 2025 ESMO Annual Congress [1]